Introduction: Palliative care is a comprehensive approach that aims to actively care for all individuals suffering from a serious illness, with the aim of providing quality of life to everyone involved in the pathological process, from early identification to the terminal phase. From a nutritional point of view, early diagnosis of malnutrition in this population is of utmost importance for the initiation of nutritional management, aiming to prevent or minimize weight loss, avoid refractory cachexia, control symptoms and improve quality of life. Objectives: To characterize the nutritional status of oncology patients receiving palliative care admitted to a referral hospital in Belém-PA. Methods: Descriptive study involving 24 oncology patients in palliative care, admitted to a reference hospital in the North Region of Brazil over a period of 6 months, approved by the Human Research Ethics Committee under CAAE number 77133424.3.0000.5550. To assess nutritional status, the Nutritional Risk Screening - NRS-2002 screening methodology was used, measuring Arm Circumference and Calf Circumference, added to the classification according to the Palliative Performance Scale. Results: All patients were at nutritional risk according to the NRS-2002 screening (100%). Of these, 95.8% presented some degree of depletion according to arm circumference and 75% were identified with low muscle mass according to the calf circumference classification. Furthermore, 100% of patients scored below 70% on the Palliative Performance Scale. Conclusion: Due to the staging of the pathology, tumor response and effects of antineoplastic treatment, the presence of malnutrition may be recurrent in cancer patients undergoing palliative care, directly reflecting on the degree of functional impairment. Such data demonstrate a worrying reality commonly seen within hospitals that provide palliative care, where patients are admitted with severe nutritional impairment already in place and in a clear process of physical suffering, a fact that goes against the provision of proportional comfort measures. Therefore, it is important to emphasize that an individualized and timely nutritional approach, associated with adequate multidisciplinary treatment, are essential to detect early signs of malnutrition, contain the progression of the nutritional condition and avoid irreversible complications.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
